Lift patent barriers to increase access to medicines, says commissionBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7545.814-c (Published 06 April 2006) Cite this as: BMJ 2006;332:814
- John Zarocostas
More action and resources are needed to improve access to life saving drugs, vaccines, and diagnostics in poor developing countries to stem the misery and death of millions of people a year, says a report by an independent commission.
The report, from the 10 member Commission on Intellectual Property Rights, Innovation, and Public Health, includes 60 recommendations on how to provide access to lifesaving medicines that are not available in poor countries.
Ruth Dreifuss, the chairwoman of the commission, said that the regulatory authorities in rich and poor countries needed to work more closely together. She also said that countries should make full use of flexibilities allowed under the rules of the trade related aspects of intellectual property rights (TRIPS), which are governed by the World …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial